Protocol Design Featured Articles

  1. What's The Risk Of Letting Researchers Use LLMs? 5/21/2025

    Who should be using AI and how? Sage Therapeutics' Jake Alme explores AI use in clinical research, examining its use shifting toward more complex applications and discussing the risk of using it in the public domain.

  2. Celebrating Clinical Trials Day, Part 2: Trial Optimization In Action 5/20/2025

    Celebrate Clinical Trials Day 2025 with these industry experts as they share experiences and advice related to trial design, regulatory and compliance, and outsourcing challenges.

  3. 5 Ways AI Is Changing Clinical Research — And How To Embrace It 5/15/2025

    Discover how AI is transforming clinical trials, learn real tools already in use, and get practical guidance for clinical professionals — especially CRAs and site teams — looking to upskill in an AI-enhanced environment.

  4. Overview Of Idiopathic Pulmonary Fibrosis: Global Clinical Trials Landscape 5/14/2025

    Explore the growing number of clinical trials and innovative approaches for Idiopathic Pulmonary Fibrosis (IPF) treatments.

  5. How Recursion Is Industrializing Clinical Trials With AI 5/12/2025

    Recursion SVP of Clinical Development and Data Science Sid Jain discusses the company's three-point "ClinTech" strategy, focusing on AI-assisted trial design, trial execution, and evidence generation.

  6. Caregiver Distress: The Hidden Burden Of Dementia With Lewy Bodies — And Why Measuring It Matters 5/7/2025

    Taking care of a loved one can be challenging. Cognition Therapeutic experts contend that caregivers’ distress levels must be evaluated to better understand the impact of dementia with Lewy bodies (DLB) on patients, families, and society.

  7. How Close Is The First FDA-Approved Full-Spectrum Botanical Drug For Autism? 5/6/2025

    AJNA BioSciences CEO Joel Stanley details his transition from helping to build one of the largest CBD companies to developing what he hopes will become an FDA-approved botanical drug to treat the symptoms of autism.

  8. Medtech CEO Shares Lessons From FIH Implantable Glucose Monitor Trial 4/30/2025

    CEO and President Paul Goode, Ph.D., explores the implantable CBGM’s trial design, as well as the company’s approach to patient input, site selection, and more for its first-in-human trial.

  9. The Future of Glaucoma Therapy: Adaptive Trial Design and Patient-Centric Protocols 4/25/2025

    Perfuse Therapeutics' Sevgi Gurkan, MD, discusses the company’s use of functional and structural endpoints, exploratory biomarkers, adaptive trial design plans, and patient-centric protocol development.

  10. Track Your Trial's Carbon Footprint With This Sustainability Calculator 4/24/2025

    Pistoia Alliance Portfolio Lead Thierry Escudier discusses the latest updates to the Clinical Trial Carbon Calculator.